Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA TrialMichael C. Kreißl, Martin Schlumberger, Lars Bastholt et al.|Journal of Clinical Oncology|2020Cited by 61
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancerLuca Giovanella, Rainer Görges, Simone Schenke et al.|European Journal of Nuclear Medicine and Molecular Imaging|2023Cited by 16